Nordea Investment Management Ab Allogene Therapeutics, Inc. Transaction History

Nordea Investment Management Ab

$85.8 Billion
Q3 2024

A detailed history of Nordea Investment Management Ab transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 451,006 shares of ALLO stock, worth $960,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares

451,006

Previous 634,660 28.94%

Holding current value

$960,642

Previous $1.48 Million 14.61%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$2.08 - $3.5 $382,000 - $642,789	-183,654 Reduced 28.94%	451,006 $1.26 Million
Q2 2024 Aug 08, 2024	SELL	$2.23 - $4.38 $239,622 - $470,648	-107,454 Reduced 14.48%	634,660 $1.48 Million
Q1 2024 May 02, 2024	BUY	$2.92 - $5.63 $4,178 - $8,056	1,431 Added 0.19%	742,114 $3.32 Million
Q4 2023 Jan 10, 2024	SELL	$2.28 - $3.5 $54,275 - $83,317	-23,805 Reduced 3.11%	740,683 $2.38 Million
Q3 2023 Nov 13, 2023	SELL	$3.17 - $5.96 $34,258 - $64,409	-10,807 Reduced 1.39%	764,488 $2.42 Million
Q2 2023 Jul 07, 2023	BUY	$4.53 - $6.74 $587,391 - $873,955	129,667 Added 20.08%	775,295 $3.85 Million
Q1 2023 Apr 19, 2023	SELL	$4.92 - $8.21 $35,360 - $59,005	-7,187 Reduced 1.1%	645,628 $3.19 Million
Q4 2022 Feb 08, 2023	SELL	$5.62 - $11.11 $64,556 - $127,620	-11,487 Reduced 1.73%	652,815 $4.11 Million
Q3 2022 Oct 19, 2022	SELL	$10.32 - $17.28 $360,229 - $603,175	-34,906 Reduced 4.99%	664,302 $6.96 Million
Q2 2022 Aug 09, 2022	SELL	$6.78 - $12.28 $409,973 - $742,547	-60,468 Reduced 7.96%	699,208 $7.87 Million
Q1 2022 Apr 11, 2022	BUY	$7.65 - $15.29 $2.62 Million - $5.23 Million	342,237 Added 81.98%	759,676 $7.28 Million
Q4 2021 Jan 20, 2022	BUY	$13.13 - $24.52 $1.47 Million - $2.75 Million	112,028 Added 36.68%	417,439 $6.46 Million
Q3 2021 Nov 01, 2021	SELL	$21.01 - $27.64 $6.42 Million - $8.44 Million	-305,411 Reduced 50.0%	305,411 $7.92 Million
Q3 2021 Nov 01, 2021	BUY	$21.01 - $27.64 $6.29 Million - $8.28 Million	299,516 Added 96.21%	610,822 $15.7 Million
Q2 2021 Jul 16, 2021	BUY	$23.49 - $35.8 $3.34 Million - $5.1 Million	142,323 Added 84.22%	311,306 $8.12 Million
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $175,965 - $266,233	-6,823 Reduced 3.88%	168,983 $5.93 Million
Q4 2020 Feb 12, 2021	SELL	$25.24 - $43.45 $86,775 - $149,381	-3,438 Reduced 1.92%	175,806 $4.44 Million
Q3 2020 Nov 09, 2020	SELL	$32.38 - $44.96 $5.71 Million - $7.93 Million	-176,302 Reduced 49.59%	179,244 $6.72 Million
Q2 2020 Aug 13, 2020	BUY	$18.39 - $54.04 $3.27 Million - $9.61 Million	177,777 Added 100.0%	355,546 $15.2 Million
Q1 2020 May 15, 2020	BUY	$18.22 - $28.25 $120,944 - $187,523	6,638 Added 3.88%	177,769 $3.46 Million
Q4 2019 Feb 11, 2020	BUY	$24.82 - $31.4 $4.25 Million - $5.37 Million	171,131 New	171,131 $4.47 Million

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $306M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Allogene Therapeutics, Inc. Transaction History